Fig. 2From: The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation studyTen-year prostate cancer and other-cause mortality rates stratified by each Cambridge Prognostic Group (CPG) category in the PCBaSe cohort (n = 72,337). Red prostate cancer mortality, blue other-cause mortalityBack to article page